GANIRELIX GH (Lupin Australia Pty Limited)
Product name
GANIRELIX GH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
108 (255 working days)
Active ingredients
ganirelix
Registration type
New generic medicine
Indication
For the prevention of premature luteinisation and ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.